Pharmaceutical innovation incentives, competition, and cost-benefit analysis in international perspective
Introduction / Frank A. Sloan and Chee-Ruey HsiehThe pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents...
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Format: | UnknownFormat |
| Sprache: | eng |
| Veröffentlicht: |
Cambridge u.a.
Cambridge Univ. Press
2007
|
| Schlagworte: |
1981-2003
> Pharmaindustrie
> Pharmakologie
> Arzneimittel
> Gesundheitswesen
> Gesundheitspolitik
> Innovation
> Patent
> Impfung
> Welt
> Pharmaceutical policy
> Pharmaceutical industry
> Drug development
> Technological innovations
> Drug Industry
> economics
> Cost-Benefit Analysis
> Economic Competition
> Health Policy
> Pharmaceutical Preparations
> Vaccines
> Kongress
> Pharmazeutische Industrie
> Konferenzschrift
> Aufsatzsammlung
> Produktinnovation
|
| Online Zugang: | Verlagsangaben Autorenbiografie Inhaltsverzeichnis |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Tag hinzufügen | Zusammenfassung: | Introduction / Frank A. Sloan and Chee-Ruey HsiehThe pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux ... [et al.] -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh ... [et al.] -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh. |
|---|---|
| Beschreibung: | Introduction / Frank A. Sloan and Chee-Ruey Hsieh -- The pharmaceutical sector in health care / Uwe E. Reinhardt -- The economics of research and development in the pharmaceutical industry / William S. Comanor -- Drugs for neglected diseases: new incentives for innovation / Aidan Hollis -- When patents fail: finding new drugs for the developing world / Stephen M. Maurer -- Implementing a public subsidy for vaccines / Frank A. Sloan and Charles E. Eesley -- Ensuring the future supply of vaccines: is a national vaccine authority the answer? / Frank R. Lichtenberg -- Competition between generic and branded drugs / Henry Grabowski -- The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned? / Ernst R. Berndt -- Measures of costs and benefits for drugs in cost-effectiveness analysis / Mark V. Pauly -- Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience / Michael Drummond -- Pharmaceutical spending and health outcomes / Pierre-Yves Cremieux ... [et al.] -- Pharmaceutical innovation and health outcomes: empirical evidence from Taiwan / Chee-Ruey Hsieh ... [et al.] -- Conclusions and policy implications / Frank A. Sloan and Chee-Ruey Hsieh. - Includes bibliographical references (p. 293-317) and index. - Formerly CIP |
| Beschreibung: | XIV, 331 S. graph. Darst. 24 cm |
| ISBN: | 0521874904 0-521-87490-4 9780521874908 978-0-521-87490-8 |